Matches in Wikidata for { <http://www.wikidata.org/entity/Q89155186> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q89155186 description "assaig clínic" @default.
- Q89155186 description "clinical trial" @default.
- Q89155186 description "clinical trial" @default.
- Q89155186 description "clinical trial" @default.
- Q89155186 description "clinical trial" @default.
- Q89155186 description "ensaio clínico" @default.
- Q89155186 description "ensayo clínico" @default.
- Q89155186 description "ensayu clínicu" @default.
- Q89155186 description "essai clinique" @default.
- Q89155186 description "klinisch onderzoek" @default.
- Q89155186 description "клінічне випробування" @default.
- Q89155186 name "Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma" @default.
- Q89155186 name "Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma" @default.
- Q89155186 type Item @default.
- Q89155186 label "Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma" @default.
- Q89155186 label "Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma" @default.
- Q89155186 prefLabel "Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma" @default.
- Q89155186 prefLabel "Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma" @default.
- Q89155186 P1050 Q89155186-B15CB85E-816B-4B71-B427-2FF1A2466854 @default.
- Q89155186 P1132 Q89155186-4B9BFB5E-E8A0-4841-80A7-E9FCFF512D95 @default.
- Q89155186 P1476 Q89155186-993F3E2E-DFE7-4649-9977-2474717DD63F @default.
- Q89155186 P17 Q89155186-B457930A-BBBD-427A-97DD-DD05D81C5F07 @default.
- Q89155186 P2899 Q89155186-0ABB2300-BCBB-4B4B-90B4-37E84B4EF8BA @default.
- Q89155186 P3098 Q89155186-5CCEC46C-F9FF-4920-8CA5-6C32FB1E0108 @default.
- Q89155186 P31 Q89155186-2631E6E7-1CB8-43FC-B0F3-468ECC77ECB8 @default.
- Q89155186 P4844 Q89155186-F66D55DC-71D5-42DF-B4D6-C1E6C82ED8CC @default.
- Q89155186 P580 Q89155186-923F4B0F-D9D9-4557-9B72-57E2B1C3810D @default.
- Q89155186 P582 Q89155186-554CF89A-1140-4882-8BD4-C88227494AA3 @default.
- Q89155186 P6099 Q89155186-0B25B25B-20C6-4A24-B04F-46FEAD5EEFC2 @default.
- Q89155186 P6099 Q89155186-A2BCF8B3-A9EF-4846-A8A1-549B0D0B7A0F @default.
- Q89155186 P8363 Q89155186-A636E8B4-6BAD-42F3-A630-930AD09F927C @default.
- Q89155186 P859 Q89155186-F6CB9031-9C8A-4B25-A8C7-16174AE6A192 @default.
- Q89155186 P1050 Q180614 @default.
- Q89155186 P1132 "+16" @default.
- Q89155186 P1476 "Adjuvant Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma" @default.
- Q89155186 P17 Q30 @default.
- Q89155186 P2899 "+16" @default.
- Q89155186 P3098 "NCT04318717" @default.
- Q89155186 P31 Q30612 @default.
- Q89155186 P4844 Q13896859 @default.
- Q89155186 P580 "2020-06-30T00:00:00Z" @default.
- Q89155186 P582 "2023-06-30T00:00:00Z" @default.
- Q89155186 P6099 Q42824440 @default.
- Q89155186 P6099 Q5452194 @default.
- Q89155186 P8363 Q78089383 @default.
- Q89155186 P859 Q7972509 @default.